Motor Neurone Disease Trial, Recruiting (NCT05744310)

Motor Neurone Disease Trial, Recruiting NCT05744310 Sponsor: Haukeland University Hospital Condition: Motor Neurone Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05744310 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Motor Neurone Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

You have been diagnosed with a condition called ALS (also known as Lou Gehrig's disease), based on recognised medical guidelines
Your ALS has progressed to a point where your doctor has recommended a type of breathing support machine used at home (called long-term mechanical ventilation)
You are able to communicate in Norwegian

For partners of ALS patients:

You are the partner of someone who has ALS and whose illness has progressed to the point where their doctor has recommended home breathing support
You are able to communicate in Norwegian

For children of ALS patients:

You are 8 years old or older and have a parent who has ALS, and whose illness has progressed to the point where their doctor has recommended home breathing support
You are able to communicate in Norwegian

Who may not be able to join:

Patients, partners, or children who have significant memory or thinking difficulties, or who have been diagnosed with dementia, may not be eligible to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ole-Bjørn Tysnes, Haukeland University Hospital

Phone: + 47 55975063

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05744310

Sponsor: Haukeland University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Motor Neurone Disease

Trial contact: + 47 55975063

More information: https://clinicaltrials.gov/study/NCT05744310

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For patients:

You have been diagnosed with a condition called ALS (also known as Lou Gehrig's disease), based on recognised medical guidelines
Your ALS has progressed to a point where your doctor has recommended a type of breathing support machine used at home (called long-term mechanical ventilation)
You are able to communicate in Norwegian

For partners of ALS patients:

You are the partner of someone who has ALS and whose illness has progressed to the point where their doctor has recommended home breathing support
You are able to communicate in Norwegian

For children of ALS patients:

You are 8 years old or older and have a parent who has ALS, and whose illness has progressed to the point where their doctor has recommended home breathing support
You are able to communicate in Norwegian

Who may not be able to join:

Patients, partners, or children who have significant memory or thinking difficulties, or who have been diagnosed with dementia, may not be eligible to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Haukeland University Hospital

Registry

ClinicalTrials.gov

Start date

21 April 2023

Est. completion

21 August 2032

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Overall quality of life assessed by the "Quality of Life Scale"; Overall quality of life assessed by the "Quality of Life Scale"; Overall quality of life assessed by the "Quality of Life Scale"; Overall quality of life assessed by the "Quality of Life Scale"; Overall quality of life assessed by the "Quality of Life Scale"

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov